Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESXB
2351
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.92M | ﹤0.01% |
216,007
+24,100
| +13% | +$209K |
|
|
AFI
2352
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.9M | ﹤0.01% |
445,649
+129,683
| +41% | +$634K |
|
2353
First Community Corp
FCCO
$323M
| $1.9M | ﹤0.01% |
87,789
| – | – |
|
2354
First US Bancshares
FUSB
$90.6M
| $1.9M | ﹤0.01% |
163,259
+19,695
| +14% | +$198K |
|
2355
Magnachip Semiconductor
MX
$139M
| $1.89M | ﹤0.01% |
163,031
-26,200
| -14% | -$307K |
|
2356
Unum
UNM
$14.8B
| $1.88M | ﹤0.01% |
64,600
-946,100
| -94% | -$27.5M |
|
2357
Thomson Reuters
TRI
$44.9B
| $1.88M | ﹤0.01% |
+24,873
| New | +$1.81M |
|
2358
Hess Midstream
HESM
$5.2B
| $1.87M | ﹤0.01% |
82,544
+71,997
| +683% | +$1.51M |
|
2359
First Internet Bancorp
INBK
$254M
| $1.87M | ﹤0.01% |
78,900
+57,200
| +264% | +$1.3M |
|
|
GBL
2360
DELISTED
GAMCO Investors, Inc.
GBL
| $1.87M | ﹤0.01% |
95,800
+15,100
| +19% | +$266K |
|
2361
Electromed
ELMD
$341M
| $1.86M | ﹤0.01% |
215,544
+91,420
| +74% | +$724K |
|
2362
Ohio Valley Banc Corp
OVBC
$210M
| $1.86M | ﹤0.01% |
47,000
-3,400
| -7% | -$128K |
|
2363
BRC Group Holdings
RILY
$299M
| $1.86M | ﹤0.01% |
73,939
+55,739
| +306% | +$1.47M |
|
2364
State Street Industrial Select Sector SPDR ETF
XLI
$34.8B
| $1.86M | ﹤0.01% |
22,800
-61,992
| -73% | -$4.95M |
|
2365
State Street Materials Select Sector SPDR ETF
XLB
$8.6B
| $1.85M | ﹤0.01% |
60,400
-177,800
| -75% | -$5.25M |
|
|
PFIE
2366
DELISTED
Profire Energy, Inc
PFIE
| $1.85M | ﹤0.01% |
1,279,085
+150,620
| +13% | +$246K |
|
|
VIOT
2367
Viomi Technology
VIOT
$47.2M
| $1.84M | ﹤0.01% |
228,390
+164,026
| +255% | +$1.41M |
|
2368
Braskem
BAK
$777M
| $1.83M | ﹤0.01% |
+123,800
| New | +$1.73M |
|
|
MAG
2369
DELISTED
MAG Silver
MAG
| $1.83M | ﹤0.01% |
+154,800
| New | +$1.6M |
|
2370
Carlyle Group
CG
$17.6B
| $1.83M | ﹤0.01% |
+56,991
| New | +$1.61M |
|
2371
Lincoln Educational Services
LINC
$950M
| $1.82M | ﹤0.01% |
673,716
-6,989
| -1% | -$14.3K |
|
2372
Cemex
CX
$16B
| $1.82M | ﹤0.01% |
480,600
-3,196,000
| -87% | -$12.2M |
|
|
NNA
2373
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $1.81M | ﹤0.01% |
212,623
+40,767
| +24% | +$324K |
|
2374
Farmers & Merchants Bancorp
FMAO
$483M
| $1.81M | ﹤0.01% |
59,900
+9,500
| +19% | +$251K |
|
2375
Alto Ingredients
ALTO
$324M
| $1.8M | ﹤0.01% |
2,772,887
+250,869
| +10% | +$142K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.